Glenmark Pharma gets USFDA nod for generic version of Brovana inhalation solution
Glenmark Pharma gets USFDA nod for generic version of Brovana inhalation solution

Glenmark Pharma gets USFDA nod for generic version of Brovana inhalation solution

Anthony Fernandes Article rating: 4.7

Glenmark Pharmaceuticals today announced that it has become one of the first generic companies to receive United States Food & Drug Administration (USFDA) approval for Arformoterol Tartrate inhalation solution, 15 mcg/2 ml, unit-dose vials, the generic version of Brovana inhalation solution of Sunovion Pharmaceuticals.   

Oriental Rail order book crosses Rs 340 crore on securing 2 new orders worth Rs 15.46 crore
Oriental Rail order book crosses Rs 340 crore on securing 2 new orders worth Rs 15.46 crore

Oriental Rail order book crosses Rs 340 crore on securing 2 new orders worth Rs 15.46 crore

Shruti Dahiwal Article rating: 4.5

Oriental Rail Infrastructure Ltd (ORIL), a domestic manufacturer and supplier of several items for the Indian Railways, announced today that it has bagged two new orders worth Rs 15.46 crore for manufacturing as well as supplying seats & berths to Indian Railways.  

Five stocks witnessing short built-up
Five stocks witnessing short built-up

Five stocks witnessing short built-up

Ganesh Pawar Article rating: 3.1

The market opened in green on June 23, 2021, overall volumes in futures & options currently stand at 4,60,20,387 contracts with a turnover of Rs. 44,30,681.47 crore.

Selling pressure intensifies in past half hour; India VIX jumps over 4 per cent & 15,800 Call option adds 43.98 lakh shares in OI
Selling pressure intensifies in past half hour; India VIX jumps over 4 per cent & 15,800 Call option adds 43.98 lakh shares in OI

Selling pressure intensifies in past half hour; India VIX jumps over 4 per cent & 15,800 Call option adds 43.98 lakh shares in OI

Karan Dsij Article rating: 4.8

The level of 15,800 is going to be a strong barrier for the bulls to cross in the near term as 15,800 Call option has seen a massive addition in the open interest. Besides, nearly 44 lakh shares have been added in the open interest in 15,800 Call option strike.  

Cipla receives USFDA nod for manufacturing generic version of Brovana
Cipla receives USFDA nod for manufacturing generic version of Brovana

Cipla receives USFDA nod for manufacturing generic version of Brovana

Shruti Dahiwal Article rating: 5.0

Cipla Ltd, a leading pharmaceutical company, announced today that it has received a go-ahead from USFDA for its abbreviated new drug application (ANDA) for Arformoterol Tartrate inhalation solution of strength 15 mcg/2 ml.  

RSS
First18271828182918301832183418351836Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR